Infokiri
| Dokumendiregister | Terviseamet |
| Viit | 13.2-7/24/2740-1 |
| Registreeritud | 11.03.2024 |
| Sünkroonitud | 26.03.2024 |
| Liik | Sissetulev dokument |
| Funktsioon | 13.2 Nakkushaiguste labor |
| Sari | 13.2-7 NHL kirjavahetus |
| Toimik | 13.2-7/2024 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | ECDC respiratory viruses |
| Saabumis/saatmisviis | ECDC respiratory viruses |
| Vastutaja | Irina Odintsova (TA, Peadirektori asetäitja (2) vastutusvaldkond, Rahvatervise labor, Nakkushaiguste labor) |
| Originaal | Ava uues aknas |
Failid
From: ECDC respiratory viruses <ECDC.Influenza@ecdc.europa.eu>
Sent: Mon, 11 Mar 2024 13:41:22 +0000
Cc: ECDC Info <ECDC.Info@ecdc.europa.eu>
Subject: FOR ACTION: ERVISS User Feedback Survey 2024
|
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
To: Operational Contact Points for Influenza, COVID-19 and SARI
Cc: National Focal Points for Viral Respiratory Diseases, National Focal Points for Surveillance, National Coordinators
Dear colleagues,
The European Centre for Disease Prevention and Control (ECDC) and WHO Regional Office for Europe have jointly developed the European Respiratory Virus Surveillance Summary (ERVISS). To improve ERVISS, ECDC and WHO Euro are launching a user survey to collect feedback on ERVISS: https://ec.europa.eu/eusurvey/runner/ERVISSFeedbackSurvey2024
The survey consists of 20 questions and should take 10-15 minutes to complete. Your feedback is very valuable to us as we continue to improve ERVISS. The deadline for completing the survey is 25 March.
The survey is an opportunity to provide overall feedback on ERVISS as well as input on any missing aspects and features. Each user is encouraged to complete their own survey, and we invite you to extend this invitation to any internal colleagues using ERVISS.
Thank you in advance for your feedback. Your insights will directly inform our efforts to improve ERVISS.
Kind regards,
The ECDC and WHO Europe respiratory virus surveillance teams
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.
